Provided by Tiger Trade Technology Pte. Ltd.

Tarsus Pharmaceuticals, Inc.

73.36
+1.141.58%
Volume:269.16K
Turnover:19.70M
Market Cap:3.22B
PE:-67.77
High:73.93
Open:72.22
Low:71.20
Close:72.22
52wk High:91.53
52wk Low:53.89
Shares:43.88M
Float Shares:35.64M
Volume Ratio:0.41
T/O Rate:0.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0824
EPS(LYR):-1.5900
ROE:-13.68%
ROA:-5.48%
PB:9.28
PE(LYR):-46.14

Loading ...

Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Jan 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2025

Major Issues Report

Form 8-K - Current report
Sep 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2025

Major Issues Report

Form 8-K - Current report
Jun 18, 2025

Major Issues Report

Form 8-K - Current report
Jun 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 01, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2025

Major Issues Report

Form 8-K - Current report